Tecentriq Approved to Help Young Patients Battle a Rare Cancer
MONDAY, Jan. 2, 2023 -- Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact. The U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq)...